Physician profile
Ellen W Friedman
NPI 1215026539
$17,610.77
in general payments reported to CMS, 2019-2025
11 companies · $1,745 in 2025
The $1,745 reported for 2025 was more than what a typical Hematology (Internal Medicine) provider received nationally (typical 2025 total: $1,177).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,418 · 2020: $2,625 · 2021: $4,629 · 2024: $194 · 2025: $1,745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,508 · Food and Beverage: $402 · Education: $30.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,507.59 |
| Food and Beverage | $401.61 |
| Education | $30.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dova Pharmaceuticals | $11,307.56 | 2019-2021 | |
| Incyte Corporation | $4,000.91 | 2019 | |
| Agios Pharmaceuticals, INC. | $1,698.82 | 2019-2025 | Pyrukynd |
| Csl Behring | $145.00 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2020 | |
| Novo Nordisk INC | $124.81 | 2025 | |
| Novartis Pharmaceuticals Corporation | $98.10 | 2019-2021 | |
| Medtronic, INC. | $41.07 | 2025 | Osteocool Rf Ablation System |
| Alexion Pharmaceuticals, INC. | $30.00 | 2024 | Ultomiris |
| Genetix Biotherapeutics INC | $20.52 | 2025 | Lyfgenia |
| Janssen Biotech, INC. | $18.98 | 2024 | Carvykti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.